Appointments and Elected Offices
- Academy of Science and Literature Mainz, Germany Commission for Medical Research (2014-present, chair since 2015)
- Baden-Wuerttemberg-International, Germany Elected Committee for the joint partnership between BW and Kanagawa (Japan) “Technologies in an aging society”, Yokohama (2015)
- British Phaarmacological Society, Fellow 2021
- European Assocation of Clinical Pharmacology and Therapy (EACPT) Council of EACPT (2010-present, re-election 2015) Executive Committee (2010-present, re-election 2015)
- European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) EFLM-ESPT working group on Personalized Laboratory Medicine (WG-PLM) (2012-present)
- European Health Foundation (EHF) Board of Trustees (2013-present)
- European Medicines Agency (EMEA) CPMP Pediatric Expert Group (PEG): Extraordinary member (2001-2004)
- German Federal Institute of Drugs and Medicinal Products (BfArM) Expert Group "Drugs for Children and Adolescents" according to AMG (2004-present, re-calls in 2006, 2009, 2011 and 2013): Full Member and Vice Chair
- German Federal Institute of Drugs and Medicinal Products (BfArM) Member of the Scientific Advisory Board (2022 - 2025)
- German Medical Association (AkdÄ) Drug Commission (2007-present)
- German Morbus Crohn/Colitis Ulcerosa Association DCCV e.V. Scientific Advisory Board (2014-present)
- German Society of Child and Adolescent Medicine Committee of Drug Safety (1998-present)
- German Society of Clinical Pharmacology (DGKliPha) Chair (2013-2018, re-election 2015)
- German Society of Experimental and Clinical Pharmacology and Toxicology (DGPT) President (2015)
- Institute of Digital Medicine (IDM Foundation) Stuttgart Executive Board (2011-2013) Board of trustees (2013-present)
- Interfaculty Centre of Pharmacogenomics and Drug Research (ICEPHA), Tübingen-Stuttgart Scientific Board and Vice Chair (2006-present)
- International Union of Basic and Clinical Pharmacology (IUPHAR) Div. Clinical Pharmacology/Sub-Committee Pharmacogenetics (2008-present) Drug Metabolism and Transporter Section Executive Board (2010-2014 Councillor, 2014-2018 Vice Chair, since 2018 Chair)
- Medical Chamber of the State Baden-Württemberg Ethical committee (2004-present) Widerspruchsausschuss postgraduate training (2015-2019)
- Natural and Medical Sciences Institute (NMI), non-profit public-law foundation, Reutlingen, Germany Deputy Chairman (2010-present)
- Robert Bosch Stiftung, Stuttgart, Germany, Selection Committee "Fast Track - Exzellenz und Führungskompetenz für Wissenschaftlerinnen auf der Überholspur" (2011,2015,2017)
- University of Helsinki, International Evaluation Board of the Election of the Erkko Professorship (2014
- Verbund Klinische Pharmakologie in Deutschland e.V., Chair of the 17th and 18th Annual Meeting 2016 and 2017
- Vienna Science and Technology Fund, Vienna, Austria, International Evaluation Board of Life Sciences Call 2016 Personalized Medicine (2015-2016)
Institutional Committees
Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart and Robert-Bosch-Hospital, Stuttgart, Germany
- Board of Scientists (1999-2005), Chair (2007- present)
- Medical Executive Board (2007-present)
Eberhard Karls University Tuebingen, Germany
- Committee for Research Strategy & Coordination, Rektorat University Tübingen (2012-present)
- Board of Members of the Comprehensive Cancer Center (CCC) University Hospital Tübingen (2009-present)
- Council of the Medical Faculty University Tübingen (2010-present)
- Extended Research Committee Med. Faculty University Tübingen (2008-present)
Community Service
- Committee for qualification as medical specialist in clinical pharmacology, Regional Medical Chamber Nordwürttemberg (2013-present)
Public (regional, federal) appointments
Federal German Ministry of Health, Berlin
- Gendiagnostikkommission (2010-2013)
- Committee of Experts on Drug Prescription (2013-2017)
Other appointments and Advisory boards
- Scientific Advisory Board, Reference Institute for Bioanalytics (Foundation for Pathobiochemistry and Molecular Diagnostics), Bonn (2014-present)
- Expert Group "HEXAL-Iinitiative drugs for children" (2004-2010)
- Initiative Medicines for Children e.V. (IKAM) (2012-present)
Awards and Honors
- Adjunct Professor for "Clinical Pharmacology" and "Biochemistry" at Yerevan State Medical University, Armenia (2018-2024)
- Thomson Reuters/Clarivate Highly Cited Researchers, rubric “Pharmacology and Toxicology”/"Cross Field" (2015/2016/2018/2020)
- Robert-Pfleger Research Award (2016)
- Conferment of the “Staufer-Medal” by the Prime Minister of Baden Württemberg (2015)
- Celebratory Speech ("Vom Wert der Arznei - Wege zu einer zielgerichteten Therapie") at the Annual Meeting of the Academy of Science and Literature, Mainz, Germany (2014)
- Member of the German National Academy of Sciences ‘Leopoldina’ (2014)
- Most cited German pharmacologist in Europe (LabTimes, 2013)
- Member of Faculty of 1000 Prime, Section Pharmacogenomics (2012-2016)
- Full Member of the Academy of Science and Literature, Mainz, Germany (2012)
- Authorization of IKP (M. Schwab) as a training center for ‘Drug information’ by the Chamber of Pharmacists of the State Baden-Württemberg (2010)
- EACPT Key lecture “Personalized Medicine beyond Pharmacogenetics”, 16th World Congress on Basic and Clinical Pharmacology, Copenhagen, Denmark (2010)
- Most cited pharmacologist in German-speaking countries (Laborjournal, 2009)
- Galenus von Pergamon Award (2005)
- Friedrich Hartmut Dost Award (2004)
- Scholarship according to the "Bayerischen Begabtenförderungsgesetz" (1983-1990)
Scientific Journal Editorial Board Memberships
Editor in Chief
- Pharmacogenetics & Genomics
- Drug Research
Section Editor
- "Pharmacogenomics and Personalized Medicine" of Genome Medicine
- Monatsschrift Kinderheilkunde, Section Editor „Drug Therapy” (2015-2019)
Editorial Boards
- British Journal of Clinical Pharmacology, Member of the International Editorial Board (2013-present)
- Clinical Chemistry (2008-2014)
- Therapeutic Drug Monitoring
- Journal of Personalized Medicine
- Biomedicine Hub (2017-2019)
- Clinical Pharmacology & Therapeutics
Book Editor
- Kiess W., Schwab M., van den Anker J. (eds) Pediatric Pharmacotherapy. Handbook of Experimental Pharmacology, vol 261. Springer, Cham, 2020
- Schwab M, Kaschka WP, Spina E (eds.). Pharmacogenomics in Psychiatry. Advances in Biological Psychiatry. Vol. 25. Karger, 2010
- Seyberth WH, Rane A, Schwab M (eds.). Handbook of Experimental Pharmacology. Pediatric Clinical Pharmacology, 14th Edition, Springer, 2011
Member of National and International Research Consortia
- DFG KFO 274 Thrombozyten - Molekulare Mechanismen und translationale Bedeutung, University of Tuebingen, Germany
- DFG German-African Cooperation Projects in Infectious diseases, University Hospital Tuebingen, Germany
- GANI_MED (Greifswald Approach to Individualized Medicine), German Federal Ministry for Education and Research (BMBF)
- German Center for Infection and Research (Dt. Zentrum für Infektionsforschung, IZF)
- German Consortium for Translational Cancer Research (Dt. Konsortium für Translationale Krebsforschung, DKTK)
- International Clinical Pharmacogenetics Implementation Consortium (Member, USA)
- International Clopidogrel Consortium (Member of Steering Committee, Baltimore, USA)
- International PGx nomenclature working group (USA- Centers for Disease Control and Prevention)
- International TPMT nomenclature committee (http://www.imh.liu.se/tpmtalleles?l=en)
- Kinacept consortium: Novel anti-inflammatory compounds for autoimmune diseases (FP7-SME-1)
- NeuRoSIS-Consortium: Efficacy and Safety of Inhaled Budesonide in very Preterm Infants at risk for Bronchiopulmonary Dysplasia (FP5 Health 2009)
- PREDICT: Holistic Multi-Scale Modeling of Targeted Protein Therapeutics Action: Towards Predicting Effective Treatment of Cancer (BMBF)
- SFB 685 “Immunotherapy: Molecular Basis and Clinical Application”, University of Tuebingen, Germany
- U-PGx consortium: Making actionable pharmacogenomics data and effective treatment optimization accessible to every European citizen“(EU, Horizon 2020)
- Verbundprojekt FORSYS-Kooperation „Ein systembiologischer Ansatz zur prädiktiven Krebstherapie“ (BMBF)
- Verbundprojekt INFORM „Individualized Therapy for Relapsed Malignancies in Childhood“, Deutsche Krebshilfe e.V. (Deutsche Kinderkrebsstiftung, DKTK)
- Virtual Liver Network (BMBF)
Coordinator of Training Site and Research Networks
- EU FP7-People-ITN: Marie Curie Initial Training Network “Fighting Drug´Failure”. Lead Applicant and Consortium heads: Schwab M & Brauch H
- U-PGx consortium: Making actionable pharmacogenomics data and effective treatment optimization accessible to every European citizen“(EU, Horizon 2020, M. Schwab, Vice Chair)
- BMBF (01ZP0502): Open label, prospective, observational, multi-centre trial in postmenopausal, hormonereceptor positive breast cancer patients treated with either tamoxifen or an aromatase inhibitor (IKP211). Study PI (since 2007)
- ICEPHA Minigraduate College Membrane associated drug targets in Oncology
- BMBF Verbundprojekt “Genotype and phenotype guided supplementation of TAMoxifen standard therapy with ENDOXifen in breast cancer patients (TAMENDOX)
Membership of Professional Bodies
- International Society of the Study of Xenobiotics (ISSX)
- American Society for Clinical Pharmacology and Therapeutics (ASCPT)
- European Society for Developmental, Perinatal & Pediatric • Pharmacology (ESDP)
- German Society of Clinical and Experimental Pharmacology (DGPT)
- German Society of Child and Adolescent Medicine (DGKJ)
- German Society of Nephrology (GPN)
Reviewing Activities with Journals
- Aliment Pharmacol Ther
- Am J Human Genet
- Ann Intern Med
- Anticancer Drugs
- Basic & Clin Pharmacol & Toxicol
- Biol Neonate
- Biochem Pharmacol
- Blood
- Breast Cancer Res Ther
- Br J Clin Pharmacol
- Br J Pharmacol
- Br Med J
- Cancer Res
- Clin Chemistry
- Clin Cancer Res
- Clin Pharmacol Therapeut
- Clin Pharmacokinet
- Diabetes
- Diabetologica
- Drug Metab Dis
- Eur J Clin Pharmacol
- Eur J Human Genet
- Expert Opin Drug Safety
- Gastroenterology
- Genes and Immunity
- Gut
- Human Mutat
- Human Mol Genet
- Inflam Bowel Dis
- Int J Cancer
- Intervent Cardiol
- JAMA
- J Am Soc Nephrol
- J Clin Oncol
- J Clin Pharmacol
- J Hepatol
- J Natl Cancer Institute
- J Pharmacol Exp Ther
- Lancet Oncol
- Leukemia
- Mol Pharmacol
- Nature
- Nature Genet
- N Engl J Med
- Oncogene
- Pediatrics
- Pediatr Nephrol
- Pharmacogenetics and Genomics Pharmacogenomics
- Pharmacogenomic J
- Placenta
- PNAS
- The Lancet
- Therapeut Drug Monitor
- Xenobiotica
